Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Distefano

Orthopaedic Surgery Paramus, NJ Medical Doctor

NPI 1407883887 CMS profile 109447

140 Route 17 North, Suite 255, Paramus, NJ 07652

Open in the dashboard

General payments

$6,266

158 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Distefano of Paramus, NJ is reported in the CMS Open Payments database as having received $6,266 across 158 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 61st percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $444 2
2024 General $48 1
2023 General $304 12
2022 General $1,063 31
2021 General $889 25
2020 General $573 25
2019 General $2,945 62

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Distefano
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Michael Distefano were reported at $444. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Michael Distefano Orthopaedic Surgery median Middle half National median
2019 $2,945 $644 $140–$2,844 $163
2020 $573 $312 $75–$1,860 $114
2021 $889 $520 $117–$2,495 $132
2022 $1,063 $598 $128–$2,731 $149
2023 $304 $461 $128–$2,264 $160
2024 $48 $497 $134–$2,475 $164
2025 $444 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $2,721 58 payments
  2. Arthrex, Inc. $1,334 5 payments
  3. DePuy Synthes Sales Inc. $389 16 payments
  4. SeaPearl Inc $317 5 payments
  5. Horizon Therapeutics plc $316 26 payments
  6. Flexion Therapeutics, Inc. $196 14 payments
  7. Cerapedics, Inc. $113 1 payment
  8. IlluminOss Medical, Inc. $85 1 payment
  9. Zimmer Biomet Holdings, Inc. $84 3 payments
  10. Terumo BCT, Inc. $79 1 payment
  11. Other $632 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,967 157 payments
  2. Education $1,299 1 payment
Products named General payments · program years 2019–2025
  1. MAKO Knees, Hips $1,483 29 payments
  2. ACCOLADE Hips $689 6 payments
  3. TRIATHLON $636 3 payments
  4. MAKO Knees, Hips $424 5 payments
  5. INSIGNIA $311 12 payments
  6. ACCOLADE Hips $202 5 payments
  7. Zilretta $196 14 payments
  8. PENNSAID $153 12 payments
  9. MONOVISC $152 7 payments
  10. ADAPT $144 1 payment
  11. Other $2,105 92 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

158 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record